Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 23, 2026

1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks

View original at finance.yahoo.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks There's no doubt that artificial intelligence (AI) stocks have been the talk of the stock market for the past few years…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • VGT is not ideal for AI exposure because it excludes major AI companies in other sectors

    60% confidence
  • Training and running AI models require lots of computing power, data storage, and networking, mostly supplied by major cloud platforms

    60% confidence
  • Now is not the time to jump ship on AI stocks despite slow start to 2026

    60% confidence
  • Artificial intelligence stocks have been the talk of the stock market for the past few years

    60% confidence
  • AWS is the largest cloud platform in the world and thousands of businesses rely on it for daily operations

    60% confidence

Data points we hold from this source

Apple Podcasts · etf weight14.33 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
1 Tech ETF to Load Up On and 1 to Avoid If You're Interested in AI Stocks — Source | Via News | ViaNews EU